1. Pros and Cons for the Development of New Antiepileptic Drugs

   • Meir Bialer
   • Matthew C. Walker
   • Josemir W. Sander

   Current Opinion 14 September 2012 Pages: 285 - 289

2. Mood Disorders in Patients with Epilepsy

   • Cynthia L. Harden
   • Martin A. Goldstein

   Therapy In Practice 14 September 2012 Pages: 291 - 302

   

3. CNS Manifestations of Cytomegalovirus Infections

   • Matthias Maschke
   • Oliver Kastrup
   • Hans-Christoph Diener

   Therapy In Practice 14 September 2012 Pages: 303 - 315

   

4. Genetic Predictors of Therapeutic Response to Clozapine

   • Dalu Mancama
   • Maria J. Arranz
   • Robert W. Kerwin

   Review Article 14 September 2012 Pages: 317 - 324

5. Brain Metastases

   • Phillip Davey

   Review Article 14 September 2012 Pages: 325 - 338

6. The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders

   • George Perry
   • Lawrence M. Sayre
   • Mark A. Smith

   Review Article 14 September 2012 Pages: 339 - 352

   

7. Potential Savings from Splitting Newer Antidepressant Medications

   • Carl I. Cohen
   • Sara I. Cohen

   Original Research Article 14 September 2012 Pages: 353 - 358

   

8. Splitting Antidepressant Medications

   • John Donoghue

   Commentary 14 September 2012 Pages: 359 - 360